2026, Number 2
<< Back Next >>
Rev Fac Med UNAM 2026; 69 (2)
Primary Breast Chondrosarcoma: A Case Report and Review of the Literature
Santiago-Sanabria L, Llano-Tostado A, Sanabria-Villegas LC, Iturralde-Rosas PP, Molina-Pérez CJ
Language: Spanish
References: 38
Page: 39-51
PDF size: 268.62 Kb.
ABSTRACT
Primary chondrosarcoma of the breast is an exceedingly rare
neoplasm, with only a limited number of cases reported in
international medical literature. In the present article, we
describe the case of a 65-year-old woman with no relevant
past medical history who presented to the breast clinic with
a palpable breast mass of six months’ duration.
Mammography was requested as the initial imaging modality,
revealing an irregular, spiculated, hyperdense mass
located in the upper outer quadrant of the left breast. Complementary
breast ultrasonography identified two irregular,
spiculated nodules with a combined size of 2.2 cm. The lesion
was classified as BI-RADS 5. Subsequently, a core needle
biopsy was performed. Histological examination demonstrated
a high-grade mesenchymal neoplasm characterized
by marked cellularity, significant cytologic atypia, and the
presence of chondrocytes with abundant eosinophilic cytoplasm,
hyperchromatic pleomorphic nuclei, and anaplastic
cells, findings consistent with a primary chondrosarcoma of
the breast.
Considering the histological grade and tumor size, the lesion
was classified as stage II according to the breast sarcoma
staging system. After discussion in a multidisciplinary breast
tumor board, a total mastectomy was performed due to the
aggressive nature of the tumor and its poor prognostic features.
Adjuvant treatment with external beam radiotherapy
directed to the chest wall was administered with the aim of
achieving local disease control. During follow-up, the patient
has remained free of recurrence during the 6 months
following completion of treatment.
Breast chondrosarcomas represent a rare spectrum of
breast tumors that predominantly affect postmenopausal
women. Clinically, they usually present as a palpable mass,
underscoring the importance of diagnostic mammography
and histological confirmation through biopsy. Immunohistochemical
markers such as S100 protein and vimentin play a
crucial role in reaching the diagnosis. The surgical approach
remains the cornerstone of treatment. The role of adjuvant
therapies remains controversial; therefore, treatment decisions
should be individualized on a case-by-case basis.
REFERENCES
International Agency for Research on Cancer. GLOBOCAN 2022: Mexico fact sheet [Internet]. Lyon (FR):IARC; 2024 [cited 2026 Jan 15]. Available from: https://tinyurl.com/2dlqf4x4
Lee JS, Yoon K, Onyshchenko M. Sarcoma of the breast: clinicalcharacteristics and outcomes of 991 patients from theNational Cancer Database. Sarcoma. 2021;2021:8828158.https://doi.org/10.1155/2021/8828158
Lahat G, Lazar A, Lev D. Sarcoma epidemiology andetiology: potential environmental and genetic factors.Surg Clin North Am. 2008;88(3):451-481. https://doi.org/10.1016/j.suc.2008.03.001
Sharma S, Sharma A, Lobo A, Sampat NY, Kumar M,Kajla R, Mohapatra SS, Mohanty SK. Primary extraskeletalmyxoid chondrosarcoma of the breast: report of a caseand literature review. Pathologica. 2022;114(3):228-237.https://doi.org/10.32074/1591-951X-303
Agrawal S, Chowdhury Z, Paul P, Mandal T. A rare caseof primary chondrosarcoma of the breast: a case report andcomprehensive literature review. Discoveries (Craiova).2024;12(3). https://doi.org/10.15190/d.2024.12
Flegg KM, Flaherty JJ, Bicknell AM, Jain S. Surgicaloutcomes of borderline breast lesions detected by needlebiopsy in a breast screening program. World J Surg Oncol.2010;8:78. https://doi.org/10.1186/1477-7819-8-78
Chow WA. Chondrosarcoma: biology, genetics, and epigenetics.F1000Res. 2018;7:F1000 Faculty Rev-1826. https://doi.org/10.12688/f1000research.15953.1
Rakha EA, Tan PH, Shaaban A, Tse GM, Esteller FC,van Deurzen CHM, et al. Do primary mammary osteosarcomaand chondrosarcoma exist? A review of a largemulti-institutional series of malignant matrix-producingbreast tumours. Breast. 2013;22(1):13-18. https://doi.org/10.1016/j.breast.2012.09.010
Nazeri E, Gouran Savadkoohi M, Majidzadeh AK, EsmaeiliR. Chondrosarcoma: an overview of clinical behavior,molecular mechanisms mediated drug resistance andpotential therapeutic targets. Crit Rev Oncol Hematol.2018;131:102-109. https://doi.org/gj3b4m
WHO Classification of Tumours Editorial Board. WHOclassification of tumours: soft tissue and bone tumours.5th ed. Vol. 3. Lyon (FR): International Agency for Researchon Cancer; 2020. Available from: https://tinyurl.com/2cfyanh5
Kennedy T, Biggart J. Sarcoma of the breast. Br J Cancer.1967;21(4):635-644. https://doi.org/10.1038/bjc.1967.76
Beltaos E, Banerjee TK. Chondrosarcoma of the breast:report of two cases. Am J Clin Pathol. 1979;71(3):345-349.https://doi.org/10.1093/ajcp/71.3.345
Gupta S, Gupta V, Aggarwal PN, Kant R, Khurana N,Mandal AK. Primary chondrosarcoma of the breast: a casereport. Indian J Cancer. 2003;40(2):77-79.
Verfaillie G, Breucq C, Perdaens C, Bourgain C, LamoteJ. Chondrosarcoma of the breast. Breast J. 2005;11(2):147-148. https://doi.org/10.1111/j.1075-122X.2005.21573.x
Gurleyik E, Yildirim U, Gunal O, Pehlivan M. Malignantmesenchymal tumor of the breast: primary chondrosarcoma.Breast Care (Basel). 2009;4(2):101-103. https://doi.org/10.1159/000212101
De Padua M, Bhandari TP. Primary mesenchymal chondrosarcomaof the breast. Indian J Pathol Microbiol.2009;52(1):129-130. https://doi.org/cwr8tt
Lakshmikantha A, Kawatra V, Varma D, Khurana N.Primary breast chondrosarcoma. Breast J. 2010;16(5):553-554. https://doi.org/10.1111/j.1524-4741.2010.00960.x
Patterson JD, Wilson JE, Dim D, Talboy GE. Primarychondrosarcoma of the breast: report of a case and reviewof the literature. Breast Dis. 2011;33(4):189-191. https://doi.org/10.3233/BD-2009-0303
Badyal RK, Kataria AS, Kaur M. Primary chondrosarcomaof male breast: a rare case. Indian J Surg. 2012;74:418-419.https://doi.org/10.1007/s12262-012-0439-2
Mujtaba SS, Haroon S, Faridi N. Primary chondrosarcomaof breast. J Coll Physicians Surg Pak. 2013;23(10):754-755.
Errarhay S, Fetohi M, Mahmoud S, Saadi H, BouchikhiC, Banani A. Primary chondrosarcoma of the breast: acase presentation and review of the literature. World JSurg Oncol. 2013;11:208. https://doi.org/10.1186/1477-7819-11-208
Sinhasan SP, Bharathi KV, Bhat RV, Dasiah SD. Primarychondrosarcoma of breast—cytology with histopathologicalcorrelation: a rare case report with review of literature.Indian J Pathol Microbiol. 2014;57(2):311-313. https://doi.org/10.4103/0377-4929.134727
Farahat A, Magdy N, Elaffandi A. Primary myxoidchondrosarcoma of the breast. Ann R Coll Surg Engl.2014;96(1):112E-114E. https://doi.org/10.1308/003588414X13824511649210
Bagri PK, Beniwal S, Sharma A. Malignant mesenchymaltumor of male breast: primary chondrosarcoma. Iran JCancer Prev. 2015;8(1):63-65.
Pasta V, Sottile D, Urciuoli P, Del Vecchio L, CustureriF, D’Orazi V. Rare chondrosarcoma of the breast treatedwith quadrantectomy instead of mastectomy: a case report.Oncol Lett. 2015;9(3):1116-1120. https://doi.org/10.3892/ol.2014.2803
Militello G, Zabbia G, Mascolino A, Kabhuli K, GulottaE, De Marco P, Incandela F, Scerrino G, GulottaG. Skin nipple sparing mastectomy: the first approach inprimary myxoid chondrosarcoma of the breast. Int J SurgCase Rep. 2017;34:130-133. https://doi.org/10.1016/j.ijscr.2017.03.016
Amadu AM, Soro D, Marras V, Satta G, Crivelli P, ContiM, Meloni GB. Primary breast chondrosarcoma: imagingand pathological findings. Eur J Radiol Open. 2017;4:138-140. https://doi.org/10.1016/j.ejro.2017.11.001
Cong Y, Fang X, Qiao G, Zou H, Lin J, Zhu S. Primaryextraskeletal myxoid chondrosarcoma with adenofibromaof the breast: a case report and literature review. Int J ClinExp Med. 2018;11(4):4317-4323.
Rao L, Kudva R, Rao RV, Kumar B. Extraskeletal myxoidchondrosarcoma of the chest wall masquerading as abreast tumor: a case report. Acta Cytol. 2002;46(2):417-421. https://doi.org/10.1159/000326743
Łukasiewicz E, Ziemiecka A, Jakubowski W, Vojinovic J,Bogucevska M, Dobruch-Sobczak K. Fine-needle versuscore-needle biopsy—which one to choose in preoperativeassessment of focal lesions in the breasts? Literature review.J Ultrason. 2017;17(71):267-274. https://doi.org/10.15557/JoU.2017.0039
Reddy TP, Rosato RR, Li X, Moulder S, Piwnica-WormsH, Chang JC. A comprehensive overview of metaplasticbreast cancer: clinical features and molecular aberrations.Breast Cancer Res. 2020;22:121. https://doi.org/10.1186/s13058-020-01353-z
Pernick N. S-100 stain. En: PathologyOutlines.com [Internet].Bingham Farms (MI): PathologyOutlines LLC;[cited 2026 Jan 18]. Available from: https://www.pathologyoutlines.com/topic/stainss100.html
Pernick N. Vimentin stain. En: PathologyOutlines.com[Internet]. Bingham Farms (MI): PathologyOutlines LLC;[cited 2026 Jan 18]. Available from: https://www.pathologyoutlines.com/topic/stainsvimentin.html
Tang CH. Molecular mechanisms of chondrosarcomametastasis. J Cell Mol Med. 2013;17(1):1-4. https://doi.org/10.1111/jcmm.12002
Cates JMM. The AJCC 8th edition staging system forsoft tissue sarcoma of the extremities or trunk: a cohortstudy of the SEER database. J Natl Compr CancNetw. 2018;16(2):144-152. https://doi.org/10.6004/jnccn.2017.7042
American Cancer Society. Soft tissue sarcoma stages [Internet].Atlanta (GA): American Cancer Society; [cited2026 Jan 17]. Available from: https://www.cancer.org/cancer/types/soft-tissue-sarcoma/detection-diagnosis-staging/staging.html
Dangoor A, Seddon B, Gerrand C, Grimer R, Whelan J,Judson I. UK guidelines for the management of soft tissuesarcomas. Clin Sarcoma Res. 2016;6:20. https://doi.org/10.1186/s13569-016-0060-4
National Comprehensive Cancer Network. Soft tissue sarcomaNCCN evidence blocks version 1.2025 [Internet].Plymouth Meeting (PA): NCCN; 2025 [cited 2026 Feb 4].Available from: https://tinyurl.com/2xhw9u7k